Subscribe
shutterstock_2094533392_michael_vi
Michael Vi / Shutterstock.com
7 July 2022Big Pharma

USPTO and FDA unite to tackle drug pricing

The US Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) have partnered to facilitate access to affordable drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Senators urge USPTO to curb ‘patent thicket’ abuse
9 June 2022   A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
USPTO unveils tool to access key FDA data
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Senators urge USPTO to curb ‘patent thicket’ abuse
9 June 2022   A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
USPTO unveils tool to access key FDA data
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

More on this story

Americas
Senators urge USPTO to curb ‘patent thicket’ abuse
9 June 2022   A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
USPTO unveils tool to access key FDA data
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York